These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30560961)

  • 1. [Maxillary osteonecrosis after denosumab treatment].
    Duininck JM; de Lange J; Rozema FR; Dubois L
    Ned Tijdschr Tandheelkd; 2018 Dec; 125(12):653-657. PubMed ID: 30560961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-related osteonecrosis (MRONJ) of the mandible and maxilla.
    Dunphy L; Salzano G; Gerber B; Graystone J
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31907213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients.
    Borumandi F; Aghaloo T; Cascarini L; Gaggl A; Fasanmade K
    Anticancer Agents Med Chem; 2015; 15(6):736-43. PubMed ID: 25807940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
    Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
    Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ; Steybe D; Poxleitner P; Schmelzeisen R; Munzenmayer C; Fuellgraf H; Stricker A; Semper-Hogg W
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of krokodil (desomorphine) use on oral health].
    van Kempen EEJ; Boswinkel WA; Brand HS
    Ned Tijdschr Tandheelkd; 2020 Jan; 127(1):13-17. PubMed ID: 32159524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful conservative treatment of jaw osteonecrosis caused by denosumab in patients with multiple bone metastasis.
    Ohga N; Sato J; Asaka T; Morimoto M; Yamazaki Y; Kitagawa Y
    J Oral Sci; 2018; 60(1):159-162. PubMed ID: 29576576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review.
    Sakkas A; Heil S; Kargus S; Rebel M; Mischkowski RA; Thiele OC
    GMS Interdiscip Plast Reconstr Surg DGPW; 2021; 10():Doc03. PubMed ID: 33928006
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgery Combined with LPRF in Denosumab Osteonecrosis of the Jaw: Case Report.
    Maluf G; Pinho MC; Cunha SR; Santos PS; Fregnani ER
    Braz Dent J; 2016; 27(3):353-8. PubMed ID: 27224573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab.
    Niibe K; Ouchi T; Iwasaki R; Nakagawa T; Horie N
    J Prosthodont Res; 2015 Jan; 59(1):3-5. PubMed ID: 25212129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.